Technical Analysis for LENZ - LENZ Therapeutics, Inc.

Grade Last Price % Change Price Change
A 27.93 3.60% 0.97
LENZ closed up 3.6 percent on Friday, November 1, 2024, on 70 percent of normal volume.
Earnings due: Nov 6
*** please verify all earnings dates ***
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Outside Day Range Expansion 0.00%
Down 3 Days in a Row Weakness 3.60%
Gapped Down Weakness 3.60%
Calm After Storm Range Contraction -0.99%
New 52 Week Closing High Bullish -2.00%
Calm After Storm Range Contraction -2.00%
Gapped Up Strength -2.00%
Upper Bollinger Band Touch Strength -2.00%
20 DMA Support Bullish 3.37%

   Recent Intraday Alerts

Alert Time
Up 5% about 21 hours ago
Rose Above Previous Day's High about 23 hours ago
Outside Day about 23 hours ago
Up 3% about 23 hours ago
60 Minute Opening Range Breakout about 23 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

LENZ is a late clinical-stage biopharmaceutical company focused on developing the first aceclidine-based eye drop to improve vision in patients diagnosed with presbyopia. LENZ’s product candidates, LNZ100 and LNZ101, are preservative-free, single-use, once-daily eye drops containing aceclidine and aceclidine plus brimonidine, respectively. LNZ100 and LNZ101 are under clinical evaluation in the registration-enabling Phase 3 CLARITY trials as potential therapies for the treatment of presbyopia, a condition impacting an estimated 1.8 billion people globally and 128 million people in the United States. LENZ is committed to commercializing an ideal pharmaceutical presbyopia solution that enhances vision for "all eyes, all day." LENZ is headquartered in San Diego, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Presbyopia

Is LENZ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 31.0
52 Week Low 6.6976
Average Volume 164,075
200-Day Moving Average 18.52
50-Day Moving Average 24.02
20-Day Moving Average 26.14
10-Day Moving Average 26.84
Average True Range 1.93
RSI (14) 59.18
ADX 34.4
+DI 31.13
-DI 14.48
Chandelier Exit (Long, 3 ATRs) 25.22
Chandelier Exit (Short, 3 ATRs) 28.20
Upper Bollinger Bands 29.18
Lower Bollinger Band 23.11
Percent B (%b) 0.79
BandWidth 23.23
MACD Line 1.10
MACD Signal Line 1.03
MACD Histogram 0.0742
Fundamentals Value
Market Cap 1.62 Billion
Num Shares 58 Million
EPS -2.23
Price-to-Earnings (P/E) Ratio -12.52
Price-to-Sales 0.00
Price-to-Book 0.86
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 31.62
Resistance 3 (R3) 31.43 30.00 31.01
Resistance 2 (R2) 30.00 29.06 30.10 30.80
Resistance 1 (R1) 28.97 28.48 29.49 29.16 30.59
Pivot Point 27.54 27.54 27.80 27.64 27.54
Support 1 (S1) 26.51 26.60 27.03 26.70 25.27
Support 2 (S2) 25.08 26.02 25.18 25.06
Support 3 (S3) 24.05 25.08 24.86
Support 4 (S4) 24.24